eVTOL stocks finished the week with sharply different stress signals. Joby Aviation closed at $8.50 on 23,294,652 shares, Archer Aviation closed at $5.42 on 21,070,920 shares, and EHang closed at $10.36 on 491,077 shares as investors weighed certification evidence, commercialization proof, and insider ownership structure across the group. Macro data (10Y yield, fed funds) was unavailable this run.
For today’s detailed market data, see Joby Daily, Archer Daily, and EHang Daily.
Can Joby scale before certification evidence fully catches up?
My view is that Joby’s roadmap is ambitious but still conditional on certification execution staying unusually clean. The constructive part of the story is real: management said its first FAA-conforming aircraft has begun flight testing for Type Inspection Authorization, and the company expects that aircraft plus five additional aircraft to support FAA pilot “for credit” TIA testing later in 2026. That matters because conforming aircraft sit much closer to the certifiable product than marketing prototypes do. In parallel, Joby is framing a manufacturing narrative around its 700,000-square-foot Dayton facility, expanded Marina capacity, a target of four aircraft per month in 2027, and long-run capacity potential of 500 aircraft per year in Dayton. Those are not trivial claims, and they help explain why the stock traded such heavy volume today.
The tension is sequencing. One conforming aircraft flying and a planned six-aircraft certification-support fleet still describe a company in the certification stage, not a company already proving repeatable commercial throughput. To move from that point to four aircraft per month next year, investors have to assume not only successful regulatory progress but also factory readiness, supplier consistency, quality control discipline, workforce scaling, and minimal test-program disruption. In aerospace, those dependencies rarely move independently. The way I see it, certification still has veto power over the production story, even if the factories exist on paper and the ambition sounds credible.
That is why I lean cautious rather than skeptical. Joby is not inventing a scale narrative out of thin air; it is pairing real test activity with real facility investment. I think that makes the roadmap early rather than irrational. Still, the market should treat the 2027 production target as conditional upside, not as base case. If later-2026 TIA work across the planned six aircraft stays on track, today’s manufacturing language will look well timed. If TIA slips or the FAA process extends, the production bridge will look stretched relative to the evidence. For background on the company’s own certification and manufacturing messaging, see Joby Aviation newsroom and Joby’s daily market summary linked above.
Does Archer’s cash runway still mask how little commercialization has been proven?
Yes, and that is the core analytical tension in Archer right now. The strongest fact in the story is the balance sheet: summary materials in today’s file set point to roughly $2.0 billion of cash at year-end 2025, which is a major asset in a capital-intensive sector where delays are common and certification cycles are slow. That cash buys time for engineering, certification, partnerships, infrastructure coordination, and launch preparation. It also helps explain why institutions still show up. ACHR closed at $5.42 on 21,070,920 shares, and ARKX held Archer at 3.77% as of April 1, 2026. Those numbers signal market attention and continued thematic sponsorship.
The problem is that runway is not the same thing as business proof. Archer’s recent quarterly revenue was only $0.30 million versus an expected $1.40 million, while the 2029 revenue outlook cited in today’s material reaches $533.9 million and implies annualized growth of 1111.8%. That gap is enormous. It tells investors the valuation debate is still being carried more by belief in compressed execution than by demonstrated commercial traction. Late-2026 passenger-flight targets, White House eIPP participation, and operational partnerships are useful signals because they show management is building pre-revenue infrastructure rather than sitting still. But they remain scaffolding, not proof that a repeatable revenue engine already exists.
My read is constructive on the financing position but cautious on the commercialization leap embedded in the forward numbers. To close the gap between a $0.30 million recent quarter and a $533.9 million 2029 revenue target, Archer needs several hard things to line up in sequence: certification, production ramp, enough aircraft or operating capacity, meaningful route density, and customers willing to pay at relevant utilization levels. If any one of those elements lags, the growth curve weakens fast. That is why I would respect the balance sheet without confusing it for validation. Investors who want management context can review Archer Investor Relations, while the market data that framed today’s question sits in the Archer Daily post linked above.
Is EHang’s newly visible insider ownership structure an underpriced dilution and governance variable?
I think it is more material than the market usually treats a routine filing cluster. Today’s disclosed Form 3 summaries showed a sizeable insider equity and RSU structure: the CFO held 2,575,000 shares including 1,600,000 RSUs, the COO disclosed 742,500 shares plus 1,327,500 RSUs, the CTO disclosed 652,500 shares plus 89,800 indirect shares, director Li disclosed 755,100 shares, director Wu disclosed 130,000 shares, and director Lau disclosed 41,000 RSUs. In aggregate, the minimum disclosed share and RSU count reached 6,313,400 Class A ordinary shares. That does not automatically imply near-term selling pressure, but it does create a clearer supply map than many investors had before these disclosures surfaced.
The important detail is that a meaningful portion of the exposure sits in RSUs and options with staged vesting rather than only in static ownership. The CFO’s RSUs include tranches vesting over two, three, and four years. The COO’s equity package is also staged across multiple years, and the CTO plus director grants add further time-based issuance risk. Because EHang notes that one ADS equals two Class A shares, U.S. investors need to translate the ordinary-share disclosures into the listed instrument correctly. Even after that adjustment, the totals are large enough to matter for governance optics, future dilution expectations, and float perception, especially because EH traded only 491,077 shares today. In a lighter-volume name, overhang concerns can matter more quickly if sentiment turns.
My directional lean is skeptical of the “nothing to see here” interpretation. This is not an immediate crisis and it is not proof of imminent insider distribution. But it does surface a real future valuation variable that operating-only narratives can miss. The way I see it, investors should model the staged equity pipeline rather than wave it away as background paperwork. For filing context, see the SEC EDGAR company search for EHang Holdings and the EHang Daily post linked above.
What to Watch Tomorrow
First, watch whether any incremental Joby certification update strengthens the case that later-2026 FAA pilot TIA testing can stay on schedule. Second, watch whether Archer adds fresh evidence beyond balance-sheet strength that narrows the gap between current revenue and its 2029 commercialization targets. Third, watch whether EHang’s next trading session treats the disclosed insider equity pipeline as background noise or as a real overhang on valuation.
This is not financial advice. Do your own research.
Follow @futurewatchlog for daily eVTOL coverage.
Previous insight: https://futurewatchlog.com/2026/04/02/evtol-daily-insight-2026-04-02/